Hite Christopher — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Hite Christopher has filed 4 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $15.50M.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-02RPRXRoyalty Pharma plcS — Open-market sale600$57.09$34K
2026-07-02RPRXRoyalty Pharma plcS — Open-market sale29.4K$56.44$1.66M
2026-07-02RPRXRoyalty Pharma plcS — Open-market sale2.6K$57.10$146K
2026-07-02RPRXRoyalty Pharma plcS — Open-market sale97.4K$56.50$5.51M
2026-06-25RPRXRoyalty Pharma plcS — Open-market sale117.6K$54.47$6.41M
2026-06-25RPRXRoyalty Pharma plcS — Open-market sale32.4K$54.11$1.75M
2026-05-08RPRXRoyalty Pharma plcA — Grant or award24.3K$0.00
2026-02-13RPRXRoyalty Pharma plcA — Grant or award26.6K$0.00
2025-08-06RPRXRoyalty Pharma plcA — Grant or award3.7K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Hite Christopher?

Hite Christopher is a corporate insider — currently tracked as EVP & Chairman, Partnering of Royalty Pharma plc (RPRX). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Hite Christopher submitted recently?

4 primary Form 4 filings in the last 90 days, covering 2 companies.

Has Hite Christopher been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 6 open-market sales ($15.50M) across all tracked filings.

Where can I see all of Hite Christopher's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Hite Christopher profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.